Sub-telomere directed gene expression during initiation of invasive aspergillosis.
Aspergillus fumigatus is a common mould whose spores are a component of the normal airborne flora. Immune dysfunction permits developmental growth of inhaled spores in the human lung causing aspergillosis, a significant threat to human health in the form of allergic, and life-threatening invasive infections. The success of A. fumigatus as a pathogen is unique among close phylogenetic relatives and is poorly characterised at the molecular level. Recent genome sequencing of several Aspergillus species provides an exceptional opportunity to analyse fungal virulence attributes within a genomic and evolutionary context. To identify genes preferentially expressed during adaptation to the mammalian host niche, we generated multiple gene expression profiles from minute samplings of A. fumigatus germlings during initiation of murine infection. They reveal a highly co-ordinated A. fumigatus gene expression programme, governing metabolic and physiological adaptation, which allows the organism to prosper within the mammalian niche. As functions of phylogenetic conservation and genetic locus, 28% and 30%, respectively, of the A. fumigatus subtelomeric and lineage-specific gene repertoires are induced relative to laboratory culture, and physically clustered genes including loci directing pseurotin, gliotoxin and siderophore biosyntheses are a prominent feature. Locationally biased A. fumigatus gene expression is not prompted by in vitro iron limitation, acid, alkaline, anaerobic or oxidative stress. However, subtelomeric gene expression is favoured following ex vivo neutrophil exposure and in comparative analyses of richly and poorly nourished laboratory cultured germlings. We found remarkable concordance between the A. fumigatus host-adaptation transcriptome and those resulting from in vitro iron depletion, alkaline shift, nitrogen starvation and loss of the methyltransferase LaeA. This first transcriptional snapshot of a fungal genome during initiation of mammalian infection provides the global perspective required to direct much-needed diagnostic and therapeutic strategies and reveals genome organisation and subtelomeric diversity as potential driving forces in the evolution of pathogenicity in the genus Aspergillus.
McDonagh
Andrew
A
Department of Microbiology, Imperial College London, London, United Kingdom.
Fedorova
Natalie D
ND
Crabtree
Jonathan
J
Yu
Yan
Y
Kim
Stanley
S
Chen
Dan
D
Loss
Omar
O
Cairns
Timothy
T
Goldman
Gustavo
G
Armstrong-James
Darius
D
Haynes
Ken
K
Haas
Hubertus
H
Schrettl
Markus
M
May
Gregory
G
Nierman
William C
WC
Bignell
Elaine
E
D000222:Adaptation, Physiological / Q000235:genetics*; D000818:Animals; D001228:Aspergillosis; D001232:Aspergillus fumigatus / Q000235:genetics* / Q000472:pathogenicity; D020869:Gene Expression Profiling; D015967:Gene Expression Regulation, Viral / Q000502:physiology*; D005814:Genes, Viral / Q000502:physiology; D051379:Mice; D016615:Telomere; D014774:Virulence / Q000235:genetics
Fungal Genet Biol. 2006 Sep;43(9):605-17
16731015
Eukaryot Cell. 2007 Sep;6(9):1562-9
17601876
Cell Mol Life Sci. 2003 Jul;60(7):1376-93
12943226
Genome Biol. 2003;4(10):R70
14519205
Eukaryot Cell. 2006 Jun;5(6):972-80
16757745
J Exp Med. 2004 Nov 1;200(9):1213-9
15504822
Cell Microbiol. 2008 Jan;10(1):134-48
17973657
EMBO Rep. 2007 Sep;8(9):864-70
17721444
Mol Microbiol. 2006 Oct;62(1):292-302
16956378
J Mol Med (Berl). 2007 Dec;85(12):1317-24
18040654
Eukaryot Cell. 2007 Sep;6(9):1552-61
17630330
Chembiochem. 2007 Sep 24;8(14):1736-43
17722120
Nature. 2005 Dec 22;438(7071):1105-15
16372000
Nature. 2005 Dec 22;438(7071):1157-61
16372010
Mol Microbiol. 2005 Feb;55(4):1072-84
15686555
Biochim Biophys Acta. 1966 Jan 11;113(1):51-6
5940632
Nat Rev Microbiol. 2005 Dec;3(12):937-47
16322742
Biol Lett. 2007 Oct 22;3(5):523-5
17686752
Mol Microbiol. 1994 Dec;14(5):917-28
7715453
PLoS Genet. 2008 Apr 11;4(4):e1000046
18404212
Methods Mol Med. 2005;117:189-207
16118453
Curr Genet. 1998 Mar;33(3):206-15
9508795
J Biol Chem. 2005 May 27;280(21):20565-72
15788394
J Clin Invest. 1982 Mar;69(3):617-31
7037853
Proc Natl Acad Sci U S A. 1984 Jun;81(12):3835-7
6203127
Nat Biotechnol. 2007 Feb;25(2):221-31
17259976
Eukaryot Cell. 2007 Sep;6(9):1656-64
17616629
Mol Gen Genet. 1998 Jun;258(5):553-7
9669338
Thorax. 1988 Jul;43(7):562-8
2463695
J Antibiot (Tokyo). 1996 Sep;49(9):958-9
8931737
Mol Microbiol. 2007 Mar;63(6):1606-28
17367383
Mol Microbiol. 2004 May;52(3):785-99
15101984
Infect Immun. 1993 Jun;61(6):2357-68
8500876
Infect Immun. 2006 Dec;74(12):6761-8
17030582
Mol Microbiol. 2007 May;64(3):614-29
17462012
Microbiol Mol Biol Rev. 2002 Sep;66(3):447-59, table of contents
12208999
Eukaryot Cell. 2005 Sep;4(9):1574-82
16151250
Clin Allergy. 1977 Nov;7(6):549-62
589785
Nature. 2005 Dec 22;438(7071):1151-6
16372009
QJM. 2007 Jun;100(6):317-34
17525130
Infect Immun. 2003 May;71(5):2819-26
12704156
Appl Environ Microbiol. 2005 Jul;71(7):3551-5
16000761
Adv Genet. 1953;5:141-238
13040135
J Cell Biol. 2006 Aug 14;174(4):509-19
16893972
Bone Marrow Transplant. 1997 Apr;19(7):753-5
9156256
BMC Genomics. 2003 Mar 23;4(1):11
12659661
J Infect Dis. 2008 Feb 1;197(3):479-86
18199036
Cell. 2005 Mar 25;120(6):831-42
15797383
PLoS Pathog. 2007 Sep 28;3(9):1195-207
17845073
Plant Cell. 1996 May;8(5):771-781
12239399
Genes Dev. 1999 Dec 15;13(24):3271-9
10617575
FEBS J. 2005 Jul;272(14):3615-30
16008561
Clin Microbiol Rev. 1999 Apr;12(2):310-50
10194462
Infect Immun. 1994 Jun;62(6):2149-57
8188335
Med Mycol. 2006 Sep 1;44(Supplement_1):S83-S85
30408938
Genes Dev. 2003 Sep 15;17(18):2245-58
12952896
J Biol Chem. 2004 Feb 20;279(8):6501-6
14645222
Science. 1991 Aug 23;253(5022):905-9
1715094
J Clin Microbiol. 1992 Jun;30(6):1580-2
1624579
Trends Microbiol. 2008 Jun;16(6):291-300
18457952
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Nucleic Acids Res. 2006 Feb 09;34(3):996-1014
16473852
Biosci Biotechnol Biochem. 2007 Jul;71(7):1697-702
17617730
J Immunol. 2006 Mar 15;176(6):3717-24
16517740
Curr Opin Microbiol. 2005 Aug;8(4):385-92
16019255
Eukaryot Cell. 2006 Oct;5(10):1807-19
17031002
Med Mycol. 2005 May;43 Suppl 1:S31-40
16110790
Curr Biol. 2007 Feb 6;17(3):R87-90
17276906
FEMS Microbiol Lett. 2007 Aug;273(2):125-32
17610516
Scand J Infect Dis. 1998;30(2):190-1
9730310
Int J Parasitol. 2003 Jan;33(1):29-45
12547344
PLoS Pathog. 2007 Apr;3(4):e50
17432932